FANTAUZZI, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 1.191
EU - Europa 325
AS - Asia 182
SA - Sud America 9
AF - Africa 8
OC - Oceania 1
Totale 1.716
Nazione #
US - Stati Uniti d'America 1.180
IT - Italia 128
SE - Svezia 68
CN - Cina 61
SG - Singapore 59
IN - India 53
FI - Finlandia 40
UA - Ucraina 26
IE - Irlanda 16
GB - Regno Unito 12
DE - Germania 10
AR - Argentina 8
BE - Belgio 7
CA - Canada 7
BG - Bulgaria 5
MY - Malesia 5
TG - Togo 5
FR - Francia 4
NL - Olanda 3
BZ - Belize 2
GR - Grecia 2
IR - Iran 2
KR - Corea 2
MX - Messico 2
RO - Romania 2
ZA - Sudafrica 2
AL - Albania 1
AU - Australia 1
BJ - Benin 1
BR - Brasile 1
RU - Federazione Russa 1
Totale 1.716
Città #
Fairfield 168
Chandler 129
Woodbridge 76
Ashburn 73
Seattle 64
Wilmington 62
Ann Arbor 61
Cambridge 55
Rome 53
Houston 51
Princeton 38
Beijing 36
San Paolo di Civitate 34
Dearborn 33
Singapore 32
Plano 31
Lawrence 22
Boston 20
Dublin 16
Fremont 14
San Diego 14
Helsinki 11
Jacksonville 11
Andover 10
Des Moines 10
Millbury 10
Federal 8
Brussels 7
Norwalk 7
Toronto 6
Boardman 5
Lomé 5
Sofia 5
Albano Laziale 4
Kunming 4
Los Angeles 4
New York 4
Phoenix 3
Redwood City 3
Santa Clara 3
Belize City 2
Bühl 2
Cleveland 2
Formia 2
Guangzhou 2
Hefei 2
London 2
Mexico City 2
Milan 2
Monmouth Junction 2
Nanchang 2
Nanjing 2
Songpa-gu 2
Tehran 2
Absecon 1
Altamura 1
Amsterdam 1
Atlanta 1
Baltimore 1
Baotou 1
Bologna 1
Bremen 1
Chaoyang 1
Chengdu 1
Dallas 1
Falls Church 1
Fasano 1
Florence 1
Frankfurt am Main 1
Fuzhou 1
Genova 1
Incisa 1
Indiana 1
Jinan 1
Lamézia 1
Leawood 1
Mannheim 1
Muizenberg 1
Offenburg 1
Olevano Romano 1
Ottawa 1
Pomezia 1
Provo 1
Redmond 1
Reston 1
Sacramento 1
San Donato Val Di Comino 1
San Mateo 1
Shenyang 1
Spinea 1
Sydney 1
Taiyuan 1
Tirana 1
Vigevano 1
Washington 1
Wuhan 1
Totale 1.272
Nome #
HIV-1 induces in vivo platelet activation by enhancing platelet NOX2 activity. 114
An oral high dose of cholecalciferol restores vitamin D status in deficient postmenopausal HIV-1-infected women independently of protease inhibitors therapy: a pilot study 100
Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative Colitis 94
Decreased apoptosis of bone marrow progenitor cells in HIV-1-infected patients during highly active antiretroviral therapy 81
Analysis of intracellular human immunodeficiency virus (HIV)-1 drug resistance mutations in multi-failed HIV-1-infected patients treated with a salvage regimen: 72-week follow-up 78
Management of HIV-1 associated hepatitis in patients with acquired immunodeficiency syndrome: role of a successful control of viral replication 68
Potential benefit of dolutegravir once daily: Efficacy and safety 66
Idiopathic CD4+ lymphocytopenia may be due to decreased bone marrow clonogenic capability 64
Dolutegravir: clinical efficacy and role in HIV therapy. 63
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial 62
Usefulness of calcaneal quantitative ultrasound stiffness for the evaluation of bone health in HIV-1-infected subjects: Comparison with dual X-ray absorptiometry 61
Analysis of the mRNA expression of DNA damage response genes in HIV infected patients 60
IMPIEGHI CLINICI DELLE IMMUNOGLOBULINE PER VIA ENDOVENOSA (IVIgG) IN PAZIENTI AFFETTI DA MALATTIA DA HIV-1 59
Lack of association of Chlamydia pneumoniae with cardiovascular diseases in virologically suppressed HIV patients 58
Rate and determinants of treatment response to different antiretroviral combination strategies in subjects presenting at HIV-1 diagnosis with advanced disease 56
MONITORING OF DRUG RESISTANCE MUTATIONS IN PROVIRAL DNA OF PATIENTS RESPONDING TO ANTIRETROVIRAL THERAPY 55
Occurrence of Buffalo Hump and Laryngeal Cancer in a HIV-1 Infected Patient with Metabolic Disorders Receiving a Rescue HAART Regimen 54
Backbone switch to abacavir/lamivudine fixed-dose combination: implications for antiretroviral therapy optimization 53
null 52
null 47
[Immunorecovery after prolonged HIV-related immunosuppression: opportunities of the new antiretroviral classes]. 43
Short-term in vivo modifications of platelet NADPH oxidase 2 (NOX2) and prostaglandin F2α in HIV-1 patients on abacavir-based therapies 43
Quantification of EBV, HHV6 and CMV DNA in gastrointestinal biopsies from HIV-1 positive patients 38
Guillain Barre syndrome in an HIV-1-infected patient after the beginning of combined antiretroviral therapy: an immune reconstitution inflammatory syndrome? 36
EBV, HHV6 AND CMV DNA DETECTION IN GASTROINTESTINAL BIOPSIES FROM HIV-1 POSITIVE PATIENTS 36
Microbial translocation, residual viremia and immune senescence in the pathogenesis of HIV-1 infection 33
EVALUATION OF ENDOTHELIAL FUNCTION AND ACTIVATION MARKERS IN HIV-1 INFECTED PATIENTS ON SUPPRESSIVE HAART AFTER SWITCHING TO ABACAVIR/LAMIVUDINE FIXED DOSE: PRELIMINARY RESULTS 30
Quantification of EBV, HHV6 and CMV DNA in gastrointestinal biopsies from HIV-1 positive patients. 29
[Health care and infective aspects in patients affected by common variable immunodeficiency assisted in the Lazio Regional Authority Reference Centre for Primary Immunodeficiencies]. 29
L’approccio al paziente coinfetto. Problematiche della terapia antiretrovirale nell’insufficienza epatica 29
Streptococcus dysgalactiae subspecies equisimilis bacteraemia in an HIV-1 patient with HBV/HCV co-infections: case report and literature review. 26
No evidence of autoimmune disorders in antiretroviral-experienced HIV-1-infected individuals after long-term treatment with raltegravir 26
Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: A Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians 17
Trends in drug resistance-associated mutations in a real-life cohort of Italian patients infected with HIV-1 17
Comparative Analysis of Real-Time Polymerase Chain Reaction Methods to TypingHLA-B*57:01in HIV-1-Positive Patients 13
null 12
Totale 1.802
Categoria #
all - tutte 4.870
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.870


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020328 0 0 3 19 33 68 66 40 40 32 19 8
2020/2021121 10 10 4 6 6 18 22 9 10 14 10 2
2021/2022314 5 17 26 10 35 8 7 31 31 25 52 67
2022/2023429 72 88 42 30 47 34 16 39 51 0 8 2
2023/2024129 7 24 8 10 9 11 0 13 0 22 18 7
2024/202531 9 22 0 0 0 0 0 0 0 0 0 0
Totale 1.802